Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

29.50 +0.55 (+1.88%)

Streaming Delayed Price Updated: 3:02 PM EDT, Apr 30, 2026 Add to My Watchlist

Price and Volume

Volume	61,297
Open	29.38
Bid (Size)	29.30 (100)
Ask (Size)	29.69 (300)
Prev. Close	28.95
Today's Range	29.07 - 30.82
52wk Range	9.390 - 950.00
Shares Outstanding	13,012,866
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Today 12:00 EDT

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before Lead Plaintiff Deadline on June 23, 2026

Today 10:00 EDT

NEW YORK, NY - April 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited (“Regencell” or the...

Via TheNewswire.com

Performance

YTD	+43.6%	+43.6%
1 Month	+26.4%	+26.4%
3 Month	-8.7%	-8.7%
6 Month	+77.6%	+77.6%
1 Year	-6.7%	-6.7%

More News

Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before Lead Plaintiff Deadline on June 23, 2026

Today 10:00 EDT

Via NewMediaWire

RGC Stock Gains 20% Pre-Market — Retail Says Shorts Are In ‘Huge Trouble’ ↗

January 08, 2026

Via Stocktwits

Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Today 9:00 EDT

From Law Offices of Howard G. Smith

Via Business Wire

Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case

April 29, 2026

Via NewMediaWire

Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case

April 29, 2026

Via TheNewswire.com

Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

April 29, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC

April 28, 2026

From Pomerantz LLP

Via GlobeNewswire

RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm

April 28, 2026

From Schall Law

Via GlobeNewswire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC

April 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

REGENCELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm

April 27, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

April 27, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

April 24, 2026

From Robbins LLP

Via Business Wire

Keep an eye on the top gainers and losers in Wednesday's session. ↗

April 01, 2026

Via Chartmill

Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now ↗

March 06, 2026

Via The Motley Fool

Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag ↗

March 05, 2026

Via The Motley Fool

Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm

March 03, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need ↗

March 01, 2026

Via The Motley Fool

Top movers in Thursday's session ↗

January 22, 2026

Via Chartmill

Thursday's session: top gainers and losers ↗

January 22, 2026

Via Chartmill

Keep an eye on the top gainers and losers in Tuesday's session. ↗

January 13, 2026

Via Chartmill

These stocks are gapping in today's session ↗

January 13, 2026

Via Chartmill

Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm

January 08, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?

Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.

What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?

Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?

The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market

What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?

The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 29.50

When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?

The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 04/30/26 03:02 PM ET

What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?

The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 383.81M

How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?

Regencell Bioscience Holdings Limited - Ordinary Shares has 384M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.